In the present study, we investigated the differential expression of ENO1 in human PDAC and adjacent non-cancer tissues, as well as peripheral blood of PDAC patients and healthy controls, to explore its clinicopathological significance, and diagnostic value as tumor marker single or combined with CA19-9. This evidence concerns the gene ENO1 and cancer.